Back to ABN AMRO Bank N.V. ABN AMRO Bank N.V.

EWEW
Showing 8 of 14 quarters

Position history for ABN AMRO Bank N.V.ABN AMRO Bank N.V.'s holdings in Edwards Lifesciences Corporation

Yes. ABN AMRO Bank holds 924,314 shares of EW (Edwards Lifesciences), worth $83.6M, as of its Q2 2026 13F filing. It increased the position by 525,889 shares (+132.0%) from Q1 2026. ABN AMRO Bank has held EW since Q2 2025, across 5 quarterly 13F filings. EW is 1.1% of ABN AMRO Bank's reported 13F portfolio.

Current Value

$83.6M

Current Shares

924,314

Total Value Change

+$72.2M

Total Shares Change

+751,111

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
924,314
+132.0%
$83.6M1.1%$90.46
76
2026-Q1
Increased
398,425
+124.5%
$32.3M0.3%$80.08
56
2025-Q4
Decreased
177,456
-1.2%
$15.1M0.1%$85.25
0
2025-Q3
Increased
179,602
+1.1%
$13.9M0.1%$77.77
34
2025-Q2
New
177,707
-
$14M0.2%$78.21
46
2025-Q1
Exited
0
-100.0%
$00.0%$72.48
0
2024-Q4
Increased
175,220
+1.2%
$12.8M0.2%$74.03
34
2024-Q3
Decreased
173,203
-0.2%
$11.3M0.2%$65.99
0

Other major holders of EW: VANGUARD GROUP INC, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used